In vivo MRI follow-up of murine tumors treated by electrochemotherapy and other electroporation-based treatments

Technology in Cancer Research and Treatment

Volumn 11, Issue 6, 2012, Pages 561-570

  Calmels, L ^a,b   Al Sakere, B ^a,c   Ruaud, J P ^a,b   Leroy Willig, A ^a,b   Mir, L M ^a,c  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b CNRS   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Bleomycin; Diffusion; Electropermeabilisation; Electroporation; Irreversible Electroporation; MRI; Tumor; Vascular lock

Indexed keywords

EID: 84868294624     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.7785/tcrt.2012.500270     Document Type: Article

References (44)

1. Mir, L. M., Banoun, H., Paoletti, C. Introduction of definite amounts of nonpermeant molecules into living cells after electropermeabiliza-tion: direct access to the cytosol. Experimental Cell Research 175, 15-25 (1988).
2. Orlowski, S., Mir, L. M. Cell electropermeabilization: a new tool for biochemical and pharmacological studies. Biochimica et Biophysica Acta 1154, 51-63 (1993).
3. Cemazar, M., Miklavcic, D., Mir, L. M., Belehradek, J., Jr., Bonnay, M., Fourcault, D., Sersa, G. Electrochemotherapy of tumours resis-tant to cisplatin: a study in a murine tumour model. Eur J Cancer 37, 1166-1172 (2001).
4. Mir, L. M., Orlowski, S., Belehradek, J., Jr., Paoletti, C. Electro-chemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer 27, 68-72 (1991).
5. Tounekti, O., Pron, G., Belehradek, J., Jr., Mir, L. M. Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depend-ing on the number of molecules internalized. Cancer Research 53, 5462-5469 (1993).
6. Poddevin, B., Orlowski, S., Belehradek, J., Jr., Mir, L. M. Very high cytotoxicity of bleomycin introduced into the cytosol of cells in cul-ture. Biochemical Pharmacology 42 Suppl, S67-75 (1991).
7. Mekid, H., Tounekti, O., Spatz, A., Cemazar, M., El Kebir, F. Z., Mir, L. M. In vivo evolution of tumour cells after the generation of double-strand DNA breaks. British Journal of Cancer 88, 1763-1771 (2003).
8. Mir, L. M., Glass, L. F., Sersa, G., Teissie, J., Domenge, C., Miklavcic, D., Jaroszeski, M. J., Orlowski, S., Reintgen, D. S., Rudolf, Z., Belehradek, M., Gilbert, R., Rols, M. P., Belehradek, J., Jr., Bachaud, J. M., DeConti, R., Stabuc, B., Cemazar, M., Coninx, P., Heller, R. Effective treatment of cutaneous and subcutane-ous malignant tumours by electrochemotherapy. British Journal of Cancer 77, 2336-2342 (1998).
9. Edhemovic, I., Gadzijev, E. M., Brecelj, E., Miklavcic, D., Kos, B., Zupanic, A., Mali, B., Jarm, T., Pavliha, D., Marcan, M., Gasljevic, G., Gorjup, V., Music, M., Vavpotic, T. P., Cemazar, M., Snoj, M., Sersa, G. Electrochemotherapy: a new technological approach in treatment of metastases in the liver. Technology in Cancer Research & Treatment 10, 475-485 (2011).
10. LeBihan, D. Molecular diffusion Nuclear Magnetic Resonance Imag-ing. Magn Reson Quaterly 7, 1-30 (1991).
11. Mazaheri, Y., Shukla-Dave, A., Hricak, H., Fine, S. W., Zhang, J., Inur-rigarro, G., Moskowitz, C. S., Ishill, N. M., Reuter, V. E., Touijer, K., Zakian, K. L., Koutcher, J. A. Prostate cancer: identification with com-bined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging-correlation with pathologic findings. Radiology 246, 480-488 (2008).
12. Woodhams, R., Ramadan, S., Stanwell, P., Sakamoto, S., Hata, H., Ozaki, M., Kan, S. & Inoue, Y. Diffusion-weighted imaging of the breast: principles and clinical applications. Radiographics 31, 1059-1084 (2011).
13. Schnapauff, D., Zeile, M., Niederhagen, M. B., Fleige, B., Tunn, P. U., Hamm, B., Dudeck, O. Diffusion-weighted echo-planar magnetic res-onance imaging for the assessment of tumor cellularity in patients with soft-tissue sarcomas. J Magn Reson Imaging 29, 1355-1359 (2009).
14. Zelhof, B., Pickles, M., Liney, G., Gibbs, P., Rodrigues, G., Kraus, S., Turnbull, L. Correlation of diffusion-weighted magnetic reso-nance data with cellularity in prostate cancer. BJU International 103, 883-888 (2009).
15. McSheehy, P. M., Weidensteiner, C., Cannet, C., Ferretti, S., Laurent, D., Ruetz, S., Stumm, M., Allegrini, P. R. Quantified tumor t1 is a generic early-response imaging biomarker for chemotherapy reflect-ing cell viability. Clin Cancer Res 16, 212-225 (2010).
16. Huuse, E. M., Jensen, L. R., Goa, P. E., Lundgren, S., Anderssen, E., Bofin, A., Gribbestad, I. S., Bathen, T. F. Monitoring the Effect of Docetaxel Treatment in MCF7 Xenografts Using Multimodal In Vivo and Ex Vivo Magnetic Resonance Methods, Histopathology, and Gene Expression. Transl Oncol 3, 252-263 (2010).
17. Jordan, B. F., Gallez, B. Surrogate MR markers of response to chemo-or radiotherapy in association with co-treatments: a retrospective analysis of multi-modal studies. Contrast Media & Molecular Imaging 5, 323-332 (2010).
18. Tounekti, O., Belehradek, J., Jr., Mir, L. M. Relationships between DNA fragmentation, chromatin condensation, and changes in flow cytometry profiles detected during apoptosis. Experimental Cell Research 217, 506-516 (1995).
19. Al-Sakere, B., Andre, F., Bernat, C., Connault, E., Opolon, P., Davalos, R. V., Rubinsky, B., Mir, L. M. Tumor ablation with irre-versible electroporation. PloS One 2, e1135 (2007).
20. Belehradek, J., Jr., Barski, G. & Thonier, M. Evolution of cell-mediated antitumor immunity in mice bearing a syngeneic chemi-cally induced tumor. Influence of tumor growth, surgical removal and treatment with irradiated tumor cells. International Journal of Cancer 9, 461-469 (1972).
21. Al-Sakere, B., Bernat, C., Andre, F., Connault, E., Opolon, P., Davalos, R. V., Mir, L. M. A study of the immunological response to tumor ablation with irreversible electroporation. Technology in Cancer Research & Treatment 6, 301-306 (2007).
22. Corovic, S., Al Sakere, B., Haddad, V., Miklavcic, D., Mir, L. M. Importance of contact surface between electrodes and treated tissue in electrochemotherapy. Technology in Cancer Research & Treatment 7, 393-400 (2008).
23. Koh, D. M., Collins, D. J. Diffusion-weighted MRI in the body: appli-cations and challenges in oncology. AJR Am J Roentgenol 188, 1622-1635 (2007).
24. Basser, P. J., Mattiello, J., LeBihan, D. Estimation of the effective self-diffusion tensor from the NMR spin echo. Journal of Magnetic Resonance 103, 247-254 (1994).
25. Le Bihan, D., Poupon, C., Amadon, A., Lethimonnier, F. Artifacts and pitfalls in diffusion MRI. J Magn Reson Imaging 24, 478-488 (2006).
26. Miller, A. J., Joseph, P. M. The use of power images to perform quantitative analysis on low SNR MR images. Magnetic Resonance Imaging 11, 1051-1056 (1993).
27. Le Bihan, D., Breton, E., Lallemand, D., Grenier, P., Cabanis, E., Laval-Jeantet, M. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 161, 401-407 (1986).
28. Agerholm-Larsen, B., Iversen, H. K., Ibsen, P., Moller, J. M., Mahmood, F., Jensen, K. S., Gehl, J. Preclinical validation of electrochemotherapy as an effective treatment for brain tumors. Cancer Research 71, 3753-3762 (2011).
29. Larkin, J. O., Collins, C. G., Aarons, S., Tangney, M., Whelan, M., O'Reily, S., Breathnach, O., Soden, D. M., O'Sullivan, G. C. Electro-chemotherapy: aspects of preclinical development and early clinical experience. Annals of Surgery 245, 469-479 (2007).
30. Morse, D. L., Galons, J. P., Payne, C. M., Jennings, D. L., Day, S., Xia, G., Gillies, R. J. MRI-measured water mobility increases in response to chemotherapy via multiple cell-death mechanisms. NMR Biomed 20, 602-614 (2007).
31. Loubinoux, I., Volk, A., Borredon, J., Guirimand, S., Tiffon, B., Seylaz, J., Meric, P. Spreading of vasogenic edema and cytotoxic edema assessed by quantitative diffusion and T2 magnetic resonance imaging. Stroke a Journal of Cerebral Circulation 28, 419-426; discussion 426-417 (1997).
32. Koh, D. M., Blackledge, M., Collins, D. J., Padhani, A. R., Wallace, T., Wilton, B., Taylor, N. J., Stirling, J. J., Sinha, R., Walicke, P., Leach, M. O., Judson, I., Nathan, P. Reproducibility and changes in the apparent diffusion coefficients of solid tumours treated with com-bretastatin A4 phosphate and bevacizumab in a two-centre phase I clinical trial. Eur Radiol 19, 2728-2738 (2009).
33. Sersa, G., Cemazar, M., Parkins, C. S., Chaplin, D. J. Tumour blood flow changes induced by application of electric pulses. Eur J Cancer 35, 672-677 (1999).
34. Sersa, G., Miklavcic, D. Electrochemotherapy of tumours. J Vis Exp (2008).
35. Gehl, J., Skovsgaard, T., Mir, L. M. Vascular reactions to in vivo electroporation: characterization and consequences for drug and gene delivery. Biochimica et Biophysica Acta 1569, 51-58 (2002).
36. Dirix, L. Y., Libura, M., Libura, J., Vermeulen, P. B., De Bruijn, E. A., Van Oosterom, A. T. In vitro toxicity studies with mitomycins and bleomycin on endothelial cells. Anti-Cancer Drugs 8, 859-868 (1997).
37. Manton, D. J., Chaturvedi, A., Hubbard, A., Lind, M. J., Lowry, M., Maraveyas, A., Pickles, M. D., Tozer, D. J., Turnbull, L. W. Neoadjuvant chemotherapy in breast cancer: early response predic-tion with quantitative MR imaging and spectroscopy. British Journal of Cancer 94, 427-435 (2006).
38. Dev, S. B., Caban, J. B., Nanda, G. S., Bleecher, S. D., Rabussay, D. P., Moerland, T. S., Gibbs, S. J., Locke, B. R. Magnetic resonance stud-ies of laryngeal tumors implanted in nude mice: effect of treatment with bleomycin and electroporation. Magnetic Resonance Imaging 20, 389-394 (2002).
39. Zhang, Y., Guo, Y., Ragin, A. B., Lewandowski, R. J., Yang, G. Y., Nijm, G. M., Sahakian, A. V., Omary, R. A., Larson, A. C. MR imag-ing to assess immediate response to irreversible electroporation for targeted ablation of liver tissues: preclinical feasibility studies in a rodent model. Radiology 256, 424-432 (2010).
40. Guo, Y., Zhang, Y., Klein, R., Nijm, G. M., Sahakian, A. V., Omary, R. A., Yang, G. Y., Larson, A. C. Irreversible electroporation therapy in the liver: longitudinal efficacy studies in a rat model of hepatocel-lular carcinoma. Cancer Research 70, 1555-1563 (2010).
41. Chenevert, T. L., McKeever, P. E., Ross, B. D. Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res 3, 1457-1466 (1997).
42. Ross, B. D., Moffat, B. A., Lawrence, T. S., Mukherji, S. K., Gebarski, S. S., Quint, D. J., Johnson, T. D., Junck, L., Robertson, P. L., Muraszko, K. M., Dong, Q., Meyer, C. R., Bland, P. H., McConville, P., Geng, H., Rehemtulla, A., Chenevert, T. L. Evaluation of can-cer therapy using diffusion magnetic resonance imaging. Molecular Cancer Therapeutics 2, 581-587 (2003).
43. Huang, M. Q., Pickup, S., Nelson, D. S., Qiao, H., Xu, H. N., Li, L. Z., Zhou, R., Delikatny, E. J., Poptani, H., Glickson, J. D. Monitoring response to chemotherapy of non-Hodgkin's lymphoma xenografts by T(2)-weighted and diffusion-weighted MRI. NMR Biomed 21, 1021-1029 (2008).
44. Thoeny, H. C., Ross, B. D. Predicting and monitoring cancer treat-ment response with diffusion-weighted MRI. J Magn Reson Imaging 32, 2-16 (2010).